Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zhe Sheng

Showing results (251-260 of 669) with videos related to

Pageof 67
Sort By:
Pharmacology & Therapeutics|February 3, 2026
Pharmacological activation of cGAS-STING pathway to reverse cancer drug resistanceYumin Wang, Yan Wang, Qingzhu Gao, et al.
Radiation Oncology (London, England)|August 30, 2011
Prognosticators and risk grouping in patients with lung metastasis from nasopharyngeal carcinoma: a more accurate and appropriate assessment of prognosisXun Cao, Rong-Zhen Luo, Li-Ru He, et al.
Acta Pharmaceutica Sinica. B|November 19, 2015
PD173074, a selective FGFR inhibitor, reverses MRP7 (ABCC10)-mediated MDRNagaraju Anreddy, Atish Patel, Kamlesh Sodani, et al.
Journal of the National Cancer Institute|November 1, 2017
Somatic Mutations and Splicing Variants of Focal Adhesion Kinase in Non-Small Cell Lung CancerBo Zhou, Gui-Zhen Wang, Zhe-Sheng Wen, et al.
Drugs of Today (Barcelona, Spain : 1998)|February 22, 2023
Nivolumab and relatlimab for the treatment of melanomaXuan-Yu Chen, Yi-Dong Li, Yuhao Xie, et al.
Experimental Cell Research|December 12, 2025
Overcoming multidrug resistance in cancer cells targeting ABC transporter ABCB1 with tyrosine kinase inhibitor: OlverembatinibBohan Zhang, Xiang Chen, Xingduo Dong, et al.
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|February 6, 2025
Rational design of peptides to overcome drug resistance by metabolic regulationMin Sun, Le He, Ran Chen, et al.
Chinese Medicine|July 25, 2024
Bridging cultures: Chinese elements in scientific illustrationsJianyou Gu, Wenying Zhang, Xianxing Wang, et al.
Recent Patents on Anti-Cancer Drug Discovery|October 2, 2023
CK2B is a Prognostic Biomarker and a Potential Drug Target for Hepatocellular CarcinomaHuiru Dai, Minling Liu, Yuxi Pan, et al.
International Journal of Biological Sciences|March 9, 2026
Triptonide-mediated PTGS2 Inhibition Induces Autophagic Cell Death to Suppress the Progression of Triple-negative Breast Cancer and Epithelial Ovarian CancerKunxiang Gong, Kai Song, Haotian Wang, et al.
Pageof 67

Showing results (251-260 of 669) with videos related to

Sort By:
Pageof 67
Pharmacology & Therapeutics|February 3, 2026
Pharmacological activation of cGAS-STING pathway to reverse cancer drug resistanceYumin Wang, Yan Wang, Qingzhu Gao, et al.
Radiation Oncology (London, England)|August 30, 2011
Prognosticators and risk grouping in patients with lung metastasis from nasopharyngeal carcinoma: a more accurate and appropriate assessment of prognosisXun Cao, Rong-Zhen Luo, Li-Ru He, et al.
Acta Pharmaceutica Sinica. B|November 19, 2015
PD173074, a selective FGFR inhibitor, reverses MRP7 (ABCC10)-mediated MDRNagaraju Anreddy, Atish Patel, Kamlesh Sodani, et al.
Journal of the National Cancer Institute|November 1, 2017
Somatic Mutations and Splicing Variants of Focal Adhesion Kinase in Non-Small Cell Lung CancerBo Zhou, Gui-Zhen Wang, Zhe-Sheng Wen, et al.
Drugs of Today (Barcelona, Spain : 1998)|February 22, 2023
Nivolumab and relatlimab for the treatment of melanomaXuan-Yu Chen, Yi-Dong Li, Yuhao Xie, et al.
Experimental Cell Research|December 12, 2025
Overcoming multidrug resistance in cancer cells targeting ABC transporter ABCB1 with tyrosine kinase inhibitor: OlverembatinibBohan Zhang, Xiang Chen, Xingduo Dong, et al.
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|February 6, 2025
Rational design of peptides to overcome drug resistance by metabolic regulationMin Sun, Le He, Ran Chen, et al.
Chinese Medicine|July 25, 2024
Bridging cultures: Chinese elements in scientific illustrationsJianyou Gu, Wenying Zhang, Xianxing Wang, et al.
Recent Patents on Anti-Cancer Drug Discovery|October 2, 2023
CK2B is a Prognostic Biomarker and a Potential Drug Target for Hepatocellular CarcinomaHuiru Dai, Minling Liu, Yuxi Pan, et al.
International Journal of Biological Sciences|March 9, 2026
Triptonide-mediated PTGS2 Inhibition Induces Autophagic Cell Death to Suppress the Progression of Triple-negative Breast Cancer and Epithelial Ovarian CancerKunxiang Gong, Kai Song, Haotian Wang, et al.
Pageof 67